MDGL
MADRIGAL PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$400.43
+1.04%Leverage
- Debt / equity
- 0.56x
- Net debt / equity
- -0.26x
- Debt / assets
- 0.25x
- Debt / EBITDA
- -2.91x
- Net debt / EBITDA
- 1.32x
Liquidity & coverage
- Current ratio
- 3.05x
- Quick ratio
- 2.78x
- Cash ratio
- 2.12x
- Interest coverage
- -4.75x
- EBITDA / interest
- -3.79x
- Working capital
- $932.9M
Cash & dividend
- FCF / debt
- -0.48x
- Cash flow / debt
- -0.44x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026